- Are stars finally aligning for Takeda in India?
- India's noodle row and spill-over effects for pharma
- Express Scripts on deal for AbbVie's Viekira: more to come beyond hepatitis C
- Scrip100: the Indian power house that leaves big pharma standing
JOB OF THE WEEK Promote your job vacancy